BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Clinical Catch-up for August 19-23

  Biopharma companies large and small are involved in numerous clinical trials. Here’s a look at some of the top stories from last week.

  August 22, 2019

   · 

  6 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, Aug. 23

  Biopharma companies strengthen their senior leadership teams and boards of directors with this week’s appointments.

  August 22, 2019

   · 

  5 min read

   · 

  Alex Keown
• Biocon’s Malaysia Insulin Glargine Manufacturing Facility Receives EU GMP Certification, Provides Fillip to its Capacity

  Biocon Ltd, Asia’s premier biopharmaceuticals company, Biocon Ltd announced that it’s subsidiary in Malaysia, Biocon Sdn.

  August 22, 2019

   · 

  3 min read
• Business

  AGS Health appoints Patrice Wolfe as new CEO

  Patrice has in-depth expertise in building and scaling healthcare platforms

  August 22, 2019

   · 

  2 min read
• FDA

  Miracor Medical Granted FDA Breakthrough Device Designation for the PiCSO Impulse System

  Miracor Medical SA has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration for its PiCSO® Impulse System for treatment of STEMI patients.

  August 22, 2019

   · 

  3 min read
• Digestive Tracker FoodMarble Secures Clinical Validation

  The start-up, which was founded in 2016, has developed a breakthrough device, AIRE, to help people overcome digestive problems.

  August 22, 2019

   · 

  3 min read
• Deals

  Davita Announces Final Results Of Self-Tender Offer

  DAVITA INC. announced the final results of its modified “Dutch auction” tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not more than $61.50, which expired at 12:00 midnight, New York City time, at the end of the day on August 16, 2019.

  August 22, 2019

   · 

  8 min read
• Pharm Country

  Merck Highlights New Data from Leading Lung Cancer Clinical Development Program at the IASLC 2019 World Conference on Lung Cancer

  Merck announced new data from the company’s leading clinical development program in lung cancer will be presented at the IASLC 2019 World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Barcelona, Spain from Sept. 7-10, 2019.

  August 22, 2019

   · 

  38 min read
• Genetown

  Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas

  Finch Therapeutics Group, Inc. announced the completion of a $53 million Series C financing.

  August 22, 2019

   · 

  4 min read
• Business

  Columbia Care Announces Collaboration with IPS Specials and Grow Biotech to Import BeneCeed™ Tablets to the United Kingdom for Clinical Study

  Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced today a collaboration with IPS Specials,

  August 22, 2019

   · 

  7 min read